Cargando…

Seguridad de la Interrupción Voluntaria del Embarazo (IVE) en dos Instituciones Prestadoras de Salud en Medellín, Colombia, en 2019. Cohorte histórica

OBJECTIVES: To characterize a cohort of women with voluntary interruption of pregnancy (VIP) and to describe intraoperative complications according to the technique used. MATERIALS AND METHODS: Descriptive study in a historical cohort of women undergoing VIP in two healthcare institutions in Medellí...

Descripción completa

Detalles Bibliográficos
Autores principales: Cárdenas-Arias, Edgar Fernando, Escudero-Cardona, Diana Elizabeth, Noreña-Mosquera, Edgar Adel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Federación Colombiana de Obstetricia y Ginecología; Revista Colombiana de Obstetricia y Ginecología 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9084360/
https://www.ncbi.nlm.nih.gov/pubmed/35503301
http://dx.doi.org/10.18597/rcog.3760
_version_ 1784703596916375552
author Cárdenas-Arias, Edgar Fernando
Escudero-Cardona, Diana Elizabeth
Noreña-Mosquera, Edgar Adel
author_facet Cárdenas-Arias, Edgar Fernando
Escudero-Cardona, Diana Elizabeth
Noreña-Mosquera, Edgar Adel
author_sort Cárdenas-Arias, Edgar Fernando
collection PubMed
description OBJECTIVES: To characterize a cohort of women with voluntary interruption of pregnancy (VIP) and to describe intraoperative complications according to the technique used. MATERIALS AND METHODS: Descriptive study in a historical cohort of women undergoing VIP in two healthcare institutions in Medellín, Colombia, in 2019. Women with pelvic infection and Sexually Transmitted Infections (STIs) were included. Consecutive sampling was used. Sociodemographic, sexual and reproductive health, clinical characteristics of the pregnancy, legal cause of the VIP, characteristics of the care process and complications of the VIP techniques up to postprocedural day 7 were the measured variables. A descriptive analysis was carried out. RESULTS: Overall, 1,520 women were identified as eligible during the study period. Of them, 46 were intervened in other institutions, leaving 1,474 candidates to enter the study. Of them, 30 were excluded because of pelvic or sexually transmitted infections. Ultimately, 1,444 pregnant women were included in the analysis. Risk to the mother's health was the most frequent legal cause in 94.3% of cases. Ninety-nine percent of women received pre-procedural counseling, and 78.4% agreed to use some form of contraception after VIP. Manual vacuum aspiration (MVA) was used in 95.6% of women and dilation and curettage (D&C) in 4.4%. Complications up to postoperative day 7 occurred in 17.56%, and there were no complications in the MVA group; 80% of women attended the follow-up visit on post-VIP day 7. CONCLUSIONS: MVA is a safe procedure which was not associated with intraperatory comoplications. D&C was associated to complications in one of each six patients. Prospective studies to assess the safety and cost of the different VIP options are required.
format Online
Article
Text
id pubmed-9084360
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Federación Colombiana de Obstetricia y Ginecología; Revista Colombiana de Obstetricia y Ginecología
record_format MEDLINE/PubMed
spelling pubmed-90843602022-05-10 Seguridad de la Interrupción Voluntaria del Embarazo (IVE) en dos Instituciones Prestadoras de Salud en Medellín, Colombia, en 2019. Cohorte histórica Cárdenas-Arias, Edgar Fernando Escudero-Cardona, Diana Elizabeth Noreña-Mosquera, Edgar Adel Rev Colomb Obstet Ginecol Investigación Original OBJECTIVES: To characterize a cohort of women with voluntary interruption of pregnancy (VIP) and to describe intraoperative complications according to the technique used. MATERIALS AND METHODS: Descriptive study in a historical cohort of women undergoing VIP in two healthcare institutions in Medellín, Colombia, in 2019. Women with pelvic infection and Sexually Transmitted Infections (STIs) were included. Consecutive sampling was used. Sociodemographic, sexual and reproductive health, clinical characteristics of the pregnancy, legal cause of the VIP, characteristics of the care process and complications of the VIP techniques up to postprocedural day 7 were the measured variables. A descriptive analysis was carried out. RESULTS: Overall, 1,520 women were identified as eligible during the study period. Of them, 46 were intervened in other institutions, leaving 1,474 candidates to enter the study. Of them, 30 were excluded because of pelvic or sexually transmitted infections. Ultimately, 1,444 pregnant women were included in the analysis. Risk to the mother's health was the most frequent legal cause in 94.3% of cases. Ninety-nine percent of women received pre-procedural counseling, and 78.4% agreed to use some form of contraception after VIP. Manual vacuum aspiration (MVA) was used in 95.6% of women and dilation and curettage (D&C) in 4.4%. Complications up to postoperative day 7 occurred in 17.56%, and there were no complications in the MVA group; 80% of women attended the follow-up visit on post-VIP day 7. CONCLUSIONS: MVA is a safe procedure which was not associated with intraperatory comoplications. D&C was associated to complications in one of each six patients. Prospective studies to assess the safety and cost of the different VIP options are required. Federación Colombiana de Obstetricia y Ginecología; Revista Colombiana de Obstetricia y Ginecología 2022-03-30 /pmc/articles/PMC9084360/ /pubmed/35503301 http://dx.doi.org/10.18597/rcog.3760 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/Este es un artículo publicado en acceso abierto bajo una licencia Creative Commons
spellingShingle Investigación Original
Cárdenas-Arias, Edgar Fernando
Escudero-Cardona, Diana Elizabeth
Noreña-Mosquera, Edgar Adel
Seguridad de la Interrupción Voluntaria del Embarazo (IVE) en dos Instituciones Prestadoras de Salud en Medellín, Colombia, en 2019. Cohorte histórica
title Seguridad de la Interrupción Voluntaria del Embarazo (IVE) en dos Instituciones Prestadoras de Salud en Medellín, Colombia, en 2019. Cohorte histórica
title_full Seguridad de la Interrupción Voluntaria del Embarazo (IVE) en dos Instituciones Prestadoras de Salud en Medellín, Colombia, en 2019. Cohorte histórica
title_fullStr Seguridad de la Interrupción Voluntaria del Embarazo (IVE) en dos Instituciones Prestadoras de Salud en Medellín, Colombia, en 2019. Cohorte histórica
title_full_unstemmed Seguridad de la Interrupción Voluntaria del Embarazo (IVE) en dos Instituciones Prestadoras de Salud en Medellín, Colombia, en 2019. Cohorte histórica
title_short Seguridad de la Interrupción Voluntaria del Embarazo (IVE) en dos Instituciones Prestadoras de Salud en Medellín, Colombia, en 2019. Cohorte histórica
title_sort seguridad de la interrupción voluntaria del embarazo (ive) en dos instituciones prestadoras de salud en medellín, colombia, en 2019. cohorte histórica
topic Investigación Original
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9084360/
https://www.ncbi.nlm.nih.gov/pubmed/35503301
http://dx.doi.org/10.18597/rcog.3760
work_keys_str_mv AT cardenasariasedgarfernando seguridaddelainterrupcionvoluntariadelembarazoiveendosinstitucionesprestadorasdesaludenmedellincolombiaen2019cohortehistorica
AT escuderocardonadianaelizabeth seguridaddelainterrupcionvoluntariadelembarazoiveendosinstitucionesprestadorasdesaludenmedellincolombiaen2019cohortehistorica
AT norenamosqueraedgaradel seguridaddelainterrupcionvoluntariadelembarazoiveendosinstitucionesprestadorasdesaludenmedellincolombiaen2019cohortehistorica